[Skip to Navigation]
Sign In
From the JAMA Network
October 13, 2015

Alternative Tobacco Products as a Second Front in the War on Tobacco

Author Affiliations
  • 1Oregon Health & Science University, Portland
  • 2Department of Pediatrics, New York University School of Medicine, New York, New York
  • 3Department of Environmental Medicine, New York University School of Medicine, New York, New York
  • 4College of Global Public Health, New York University, New York, New York
JAMA. 2015;314(14):1507-1508. doi:10.1001/jama.2015.11394

Tobacco use remains a pediatric disease because 9 of 10 smokers begin smoking before their 18th birthday.1 Nearly half a million US citizens die prematurely each year from smoking-related diseases, with substantial economic consequences.1 To address these continued problems, the Family Smoking Prevention and Tobacco Control Act was enacted in June 2009 and empowered the US Food and Drug Administration (FDA) to regulate the manufacture, sale, marketing, and distribution of tobacco products. Under the act, the FDA can restrict marketing and sales of tobacco products to youth, mandate reporting of ingredients and additives, ban cigarette flavorings, and review manufacturers’ claims regarding allegedly lower-risk products.

Add or change institution